| Literature DB >> 34466515 |
Masoud Hashemi1, Payman Dadkhah1, Mehrdad Taheri1, Mahshid Ghasemi2, Ali Hosseinpour3, Mojtaba Farjam3.
Abstract
BACKGROUND: Cervical radiculopathy caused by disc herniation is a frequent public health issue with economical and socio-professional impacts. The objective of the present study is to evaluate the patient-reported outcomes and satisfaction from cervical epidural steroid injection during a 2-year follow-up.Entities:
Keywords: Epidural; Injection; Neck Pain; Pain Management; Radiculopathy; Steroids
Year: 2019 PMID: 34466515 PMCID: PMC8343784 DOI: 10.31661/gmj.v8i0.1478
Source DB: PubMed Journal: Galen Med J ISSN: 2322-2379
Participants’ Baseline and Demographic Characteristics.
|
|
|
|
|
| ||
| Male | 12 | 32.4 |
| Female | 25 | 67.6 |
|
| 20 | 54.1 |
|
| ||
| C4-5 | 5 | 13.5 |
| C5-6 | 5 | 13.5 |
| C6-7 | 3 | 8.1 |
| C3-4, C4-5 | 1 | 2.7 |
| C4-5, C5-6 | 4 | 10.8 |
| C3-4, C4-5, C5-6, C6-7 | 1 | 2.7 |
| C5-6, C6-7 | 13 | 35.1 |
| C4-5, C5-6, C6-7 | 3 | 8.1 |
| C3-4, C4-5, C5-6 | 2 | 5.4 |
|
| ||
| Central | 14 | 37.8 |
| Left paracentral | 8 | 21.6 |
| Right paracentral | 7 | 18.9 |
| Central and left paracentral | 7 | 18.9 |
| Central and right paracentral | 1 | 2.7 |
|
| ||
| Both upper extremity | 13 | 35.1 |
| Left upper extremity | 14 | 37.8 |
| Right upper extremity | 9 | 24.3 |
| Foraminal stenosis | 20 | 54.1 |
| Paresthesia | 28 | 75.7 |
| Positive Spurling test | 31 | 83.8 |
| Axial loading | 20 | 54.1 |
| Lhermitte’s Sign | 10 | 27.0 |
Frequency of Opioid Consumption, Additional Intervention, and Surgery
| Frequency (n=34) | Percentage | |
| Opioid consumption | 7 | 20.6% |
| Additional cervical epidural steroid injections | 11 | 32.4% |
| Surgery | 4 | 11.8% |
Comparison of Outcomes Stratified by Pursuit of Surgery
| Variables | Progression to surgery (n=4) |
No surgery | |
| NRS | Baseline | 8.25 | 7.7 |
| After 2 years | 7.5 | 4.6 | |
| NDI (at baseline) | Baseline | 16.5 | 21.13 |
| After 2 years | 26 | 16.23 | |
| PSQ (after 2 years) | 1.5 | 3.4 | |
| Opioid consumption (during 2 years) | 75% | 13% | |
| Additional injection (during 2 years) | 75% | 26% | |